Kura Oncology Inc’s recently made public that its Chief Legal Officer Bair Teresa Brophy unloaded Company’s shares for reported $9292.0 on May 19 ’25. In the deal valued at $5.96 per share,1,559 shares were sold. As a result of this transaction, Bair Teresa Brophy now holds 107,948 shares worth roughly $0.73 million.
Then, FORD KATHLEEN sold 1,558 shares, generating $9,777 in total proceeds. Upon selling the shares at $6.28, the Chief Operating Officer now owns 21,367 shares.
Before that, FORD KATHLEEN bought 1,558 shares. Kura Oncology Inc shares valued at $9,286 were divested by the Officer at a price of $5.96 per share.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Monday, Kura Oncology Inc [NASDAQ:KURA] saw its stock unchanged to $6.73. Over the last five days, the stock has gained 6.83%. Kura Oncology Inc shares have fallen nearly -22.73% since the year began. Nevertheless, the stocks have fallen -69.11% over the past one year.
Levels Of Support And Resistance For KURA Stock
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
